Clinical Trials Directory

Trials / Completed

CompletedNCT06796205

Evaluation of the Photoprotection Efficacy of Three Sunscreen Products Under Visible Light Exposure.

Assessment of the Protective Effects of Three Sunscreen Products on Visible Light Induced Pigmentation Compared with an Untreated Control Zone

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Cosmetique Active International · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

To evaluate the protective effect of three sunscreens products on the pigmentation caused by visible light in comparison to an untreated control zone in healthy volunteers.

Detailed description

The sunscreens usually used as photoprotectors are known to protect in the UV domain (UVB and UVA). However, until recently visible light (400-700 nm) was considered as devoid of any photobiological effects on cutaneous tissue. Over the last two decades, with the development of photodynamic therapies and various dermatological treatments using visible laser light, several studies have reconsidered the cutaneous effect of visible light on the skin, in particular the induction of pigmentation. The aim of this study was to assess the ability of sunscreens with a protective efficacy in the UV domain to prevent the pigmentation induced by Visible Light.

Conditions

Interventions

TypeNameDescription
OTHERTreated zones exposed with Visible Light sourceThe treated zones were exposed to Visible Light to induce skin pigmentation (144J/cm2), 15 to 30 minutes after application.
OTHERUntreated zone exposed with Visible Light sourceThe untreated zone was exposed to Visible Light to induce skin pigmentation (144J/cm2), as the same time as the treated zones.

Timeline

Start date
2021-06-09
Primary completion
2021-07-16
Completion
2021-07-16
First posted
2025-01-28
Last updated
2025-01-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06796205. Inclusion in this directory is not an endorsement.